Download Mobile App

Video Library

Events

more events

05 Mar 2026 - 07 Mar 2026

53rd Annual Meeting of the Japanese Society of Intensive Care Medicine (JSICM)

10 Mar 2026 - 12 Mar 2026

Medical Japan 2026 Osaka – International Medical and Elderly Care Expo.

13 Mar 2026 - 16 Mar 2026

41st Annual EAU Congress – European Association of Urology

Partner Sites

MedImaging

AI Tool Predicts Side Effects from Lung Cancer Treatment

Reusable Gel Pad Made from Tamarind Seed Could Transform Ultrasound Examinations

New Material Boosts MRI Image Quality

AI Model Accurately Detects Placenta Accreta in Pregnancy Before Delivery

AI Model Reads and Diagnoses Brain MRI in Seconds

New Treatment for Allergies Shows Promise

By HospiMedica staff writers
Posted on 10 Dec 2002

Precinical studies have shown promising results for a new allergy therapy based on Notch, a cell surface protein able to switch off an immune response to a specific allergen.

By inducing antigen-specific regulatory T cells to re-direct the immune response, an antigen is presented to the immune system in the presence of a Notch stimulator. More...

In addition to switching off the allergic response, the body learns to tolerate the antigen so that future contact does not result in the mounting of an allergic response. In the preclinical studies, treatment with a Notch stimulator/dust mite antigen combination delivered by needle-free, particle-mediated delivery resulted in a significant modification of the immune response.

The new approach was developed by Lorantis Ltd. (Cambridge, UK). The delivery system was supplied by PowderJect Pharmaceuticals Plc (Oxford), which is developing a broad range of vaccines based on its delivery technology.

Related Links:
Lorantis
PowderJect

Visit expo >

Gold Member

Real-Time Diagnostics Onscreen Viewer

GEMweb Live

Antipsychotic TDM Assays
Saladax Antipsychotic Assays

Syringes

Prefilled Saline Flush Syringes

Endoscopy Display

E190

Read the full article by registering today, it's FREE!

Free digital version edition of HospiMedica International sent by email on regular basis
Free print version of HospiMedica International magazine (available only outside USA and Canada).
Free and unlimited access to back issues of HospiMedica International in digital format
Free HospiMedica International Newsletter sent every week containing the latest news
Free breaking news sent via email
Free access to Events Calendar
Free access to LinkXpress new product services
REGISTRATION IS FREE AND EASY!